AMRI names new CEO 11th January 2018
AMRI, a contract research, development, and manufacturing organization, has appointed Michael Mulhern as chief executive officer, succeeding William S. Marth. Marth will remain with the company in an advisory role.
Mulhern was previously chief executive officer of Sterigenics International, an Oak Brook, Illinois-headquartered provider of contract sterilization, gamma technologies, and medical isotopes.
AMRI is a portfolio company of The Carlyle Group and GTCR, two investment firms, which acquired AMRI in August 2017. Since 2002, Mulhern has been CEO of three companies backed by GTCR—Sterigenics International, Fairmont Food Group, and American Sanitary—where he worked in product development, operational excellence, quality customer service, and global growth. He previously held roles at Baxter International and Alliant Foodservice, a food distributor.